Daridorexant Impurity 24 - Request Quote
Daridorexant Impurity 24
| SZ CAT No: | SZ-D142025 |
| CAS No | NA |
| Mol.F. | C23H23ClN6O2 |
| Mol.Wt. | 450.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Daridorexant Impurity 24 is chemically (R)-(2-(5-Chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone. Daridorexant Impurity 24 is supplied with detailed characterization data compliant with regulatory guideline. Daridorexant Impurity 24 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Daridorexant.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Daridorexant Impurity 24
Purchase Daridorexant Impurity 24
Daridorexant Impurity 24 suppliers
Daridorexant Impurity 24 manufacturers
Daridorexant Impurity 24 price
Order Daridorexant Impurity 24
Enquire Daridorexant Impurity 24
Daridorexant Impurity 24 cost
Daridorexant Impurity 24 Supplier
Daridorexant Impurity 24 Distributor
Daridorexant Impurity 24 for Method Validation
Daridorexant Reference Standard
Daridorexant Impurity 24 for ANDA Filing
Daridorexant Impurity 24 for Forced Degradation Studies
Daridorexant Impurity 24 Identification Standards
Daridorexant Impurity 24 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


